142 related articles for article (PubMed ID: 1405325)
1. Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD.
Kandoussi A; Cachera C; Pagniez D; Dracon M; Fruchart JC; Tacquet A
Kidney Int; 1992 Aug; 42(2):424-5. PubMed ID: 1405325
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
3. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein (a) levels in patients undergoing continuous ambulatory peritoneal dialysis.
Guindeo C; Vega N; Fernandez AM; Palop L; Aguilar JA; Moreda A; Cia P
Perit Dial Int; 1996; 16 Suppl 1():S236-40. PubMed ID: 8728199
[TBL] [Abstract][Full Text] [Related]
5. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Lang U; Reitinger J; Pinter G; Utermann G; Dieplinger H
J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
[TBL] [Abstract][Full Text] [Related]
7. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
[TBL] [Abstract][Full Text] [Related]
8. Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD.
Yang WS; Min WK; Park JS; Kim SB
Am J Kidney Dis; 1997 Oct; 30(4):507-13. PubMed ID: 9328365
[TBL] [Abstract][Full Text] [Related]
9. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) levels in end-stage renal failure and renal transplantation.
Barbagallo CM; Averna MR; Sparacino V; Galione A; Caputo F; Scafidi V; Amato S; Mancino C; Cefalù AB; Notarbartolo A
Nephron; 1993; 64(4):560-4. PubMed ID: 8366981
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease.
Trenkwalder E; Gruber A; König P; Dieplinger H; Kronenberg F
Kidney Int; 1997 Dec; 52(6):1685-92. PubMed ID: 9407518
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis.
Thillet J; Faucher C; Issad B; Allouache M; Chapman J; Jacobs C
Am J Kidney Dis; 1993 Jul; 22(1):226-32. PubMed ID: 8322787
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) and treatment of chronic renal disease.
Buggy D; Breathnach A; Keogh B; Cooke T; Feely J
J Intern Med; 1993 Nov; 234(5):453-5. PubMed ID: 8228788
[TBL] [Abstract][Full Text] [Related]
14. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
Zwolińska D; Szprynger K
Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
[TBL] [Abstract][Full Text] [Related]
15. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
[TBL] [Abstract][Full Text] [Related]
16. Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients.
Bartens W; Nauck M; Schollmeyer P; Wanner C
Perit Dial Int; 1996; 16(1):27-33. PubMed ID: 8616169
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis.
Irish AB
Metabolism; 1997 Jan; 46(1):36-40. PubMed ID: 9005966
[TBL] [Abstract][Full Text] [Related]
19. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?
Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P
Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917
[TBL] [Abstract][Full Text] [Related]
20. High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.
Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
Clin Nephrol; 1992 Nov; 38(5):271-6. PubMed ID: 1451340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]